The device will be used to treat bloodstream infections that are the leading cause of death in critically ill patients and soldiers injured in combat.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency (DARPA) to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.
The device will be used to treat bloodstream infections that are the leading cause of death in critically ill patients and soldiers injured in combat.
To rapidly cleanse the blood of pathogens, the patient’s blood is mixed with magnetic nanobeads coated with a genetically engineered version of a human blood ‘opsonin’ protein that binds to a wide variety of bacteria, fungi, viruses, parasites, and toxins. It is then flowed through microchannels in the device where magnetic forces pull out the bead-bound pathogens without removing human blood cells, proteins, fluids, or electrolytes — much like a human spleen does. The cleansed blood then flows back to the patient.
“In just a few years we have been able to develop a suite of new technologies, and to integrate them to create a powerful new device that could potentially transform the way we treat sepsis,” said Wyss founding director and project leader, Don Ingber, M.D., Ph.D. “The continued support from DARPA enables us to advance our device manufacturing capabilities and to obtain validation in large animal models, which is precisely what is required to enable this technology to be moved towards testing in humans.”
The Latest Bing News on:
Sepsis
- Weigh In Social Factors Along with Clinical Conditions When Predicting Sepsis Riskson May 17, 2022 at 5:17 am
A new study indicates that social factors, when built into sepsis readmission models, can help predict which patients are at risk of an unplanned readmission within 30 days.
- Sepsis Diagnostics Market Report 2022-2027, Size, Growth, Competitive Analysis and Industry Trendson May 17, 2022 at 2:02 am
According to IMARC Group’s latest report, titled “Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast ...
- Sepsis Alliance Launches Sepsis Innovation Collaborativeon May 16, 2022 at 1:00 am
New collaboration will bring together stakeholders across the continuum of diagnosis, treatment, and care to advance innovative solutions to sepsis and save lives.
- nz.finance.yahoo.comon May 13, 2022 at 6:37 am
New York, May 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product ...
- Sepsis Diagnostics Market Worth $1,226.52 Million, Globally, by 2028 at 9.2% CAGR - Exclusive Report by The Insight Partnerson May 13, 2022 at 6:32 am
The sepsis diagnostics market size is projected to reach $1,226.52 million by 2028 from $661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028.New York, May 13, 2022 ...
- Global Sepsis Diagnostics Market Worth to top US$ 1.6 Billion by 2032, Sales of Assays & Reagents to Soar: Fact.MRon May 11, 2022 at 8:45 am
Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Instruments, Assays & Reagents), by Method (Conventional, Automated), by Pathogen (Gram-Negative, Gram-Positive), by Technology ...
- How is the Antimicrobial Resistance Crisis Impacting Sepsis?on May 11, 2022 at 4:57 am
insights from industryDr. Ron DanielsFounder and Chief ExecutiveUK Sepsis Trust In this interview, News-Medical talks to Dr. Ron Daniels about his work at the UK Sepsis Trust, the impacts of the ...
- ‘My 20-year-old daughter died from sepsis – after the NHS failed her’on May 8, 2022 at 9:34 am
But I think about her every minute of the day’ Credit: JAY WILLIAMS It’s been four years since Sharon Rideout’s daughter Chloe died suddenly from sepsis at the age of 20, but the pain is ...
- Sepsis took me from this selfie to a coma in hourson May 7, 2022 at 4:30 pm
Kimberley Bradley with husband Nathan and daughter Lucy on the day she fell ill with sepsis When Kimberley Bradley took herself to bed feeling "a bit fluey" in April 2019, she did not know that it ...
- Warwick Davis: Star on 'life-threatening' sepsis after his wife 'prepared to die'on May 6, 2022 at 3:19 pm
You can unsubscribe at any time. More info Sammy, who shares two children with actor Davis, first spoke about her ordeal with sepsis and other related conditions back in 2018. The health scare was ...
The Latest Google Headlines on:
Sepsis
[/vc_column_text]
The Latest Bing News on:
Sepsis therapeutic device
- Spectral Medical Announces Appointment of Leading Industry Executive Sam Amory as Dialco Presidenton May 16, 2022 at 6:17 am
Previously launched start-up division for a major medical device company that grew to the number two position in the U.S. market TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc.
- Spectral to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thon May 13, 2022 at 7:04 am
PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA ...
- Spectral to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thon May 13, 2022 at 7:01 am
TORONTO, ON / ACCESSWIRE / May 13, 2022 / Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as ...
- Sepsis Diagnostics Market Worth $1,226.52 Million, Globally, by 2028 at 9.2% CAGR - Exclusive Report by The Insight Partnerson May 13, 2022 at 6:38 am
New York, May 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Sepsis Diagnostics Market Forecast ... Microfluidic Sensors, Devices, Micropumps, Microneedles, and ...
- nz.finance.yahoo.comon May 13, 2022 at 6:37 am
New York, May 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Sepsis Diagnostics Market Forecast ... Microfluidic Sensors, Devices, Micropumps, Microneedles, and ...
- Turkish biotechnology company has developed an effective treatment system for viruses and bacteriaon May 9, 2022 at 5:55 am
AVB Biotech has announced that it has completed clinical studies on virus types that cause deadly epidemics with the ’Signal Therapy’ system it has developed. It was stated that the treatment had a 95 ...
- Sepsis Diagnostics Market to Reach $1.2 Bn, Globally, by 2030 at 7.8% CAGR: Allied Market Researchon May 5, 2022 at 8:12 am
Covid-19 scenario- The global spread of COVID-19 and the emergence of sepsis cases among the patients boosted the demand for rapid diagnosis, resulting in faster adoption of devices, reagents ...
